Stifel Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
33,490
-5,792
| -15% | -$318K | ﹤0.01% | 1899 |
|
|
2025
Q1 | $2.78M | Buy |
39,282
+7,385
| +23% | +$522K | ﹤0.01% | 1527 |
|
|
2024
Q4 | $2.1M | Buy |
31,897
+1,360
| +4% | +$89.4K | ﹤0.01% | 1740 |
|
|
2024
Q3 | $2.15M | Sell |
30,537
-13,487
| -31% | -$948K | ﹤0.01% | 1719 |
|
|
2024
Q2 | $3.62M | Buy |
44,024
+124
| +0.3% | +$10.2K | ﹤0.01% | 1327 |
|
|
2024
Q1 | $3.83M | Sell |
43,900
-5,776
| -12% | -$504K | ﹤0.01% | 1305 |
|
|
2023
Q4 | $4.79M | Buy |
49,676
+4,468
| +10% | +$431K | 0.01% | 1117 |
|
|
2023
Q3 | $4M | Buy |
45,208
+7,043
| +18% | +$623K | 0.01% | 1153 |
|
|
2023
Q2 | $3.31M | Sell |
38,165
-866
| -2% | -$75.1K | ﹤0.01% | 1298 |
|
|
2023
Q1 | $3.8M | Sell |
39,031
-4,609
| -11% | -$448K | 0.01% | 1179 |
|
|
2022
Q4 | $4.52M | Buy |
43,640
+1,669
| +4% | +$173K | 0.01% | 1040 |
|
|
2022
Q3 | $3.56M | Buy |
41,971
+2,506
| +6% | +$213K | 0.01% | 1117 |
|
|
2022
Q2 | $3.27M | Sell |
39,465
-6,527
| -14% | -$541K | 0.01% | 1189 |
|
|
2022
Q1 | $3.55M | Sell |
45,992
-84,284
| -65% | -$6.5M | ﹤0.01% | 1239 |
|
|
2021
Q4 | $11.5M | Sell |
130,276
-9,351
| -7% | -$826K | 0.02% | 685 |
|
|
2021
Q3 | $10.8M | Sell |
139,627
-22,967
| -14% | -$1.78M | 0.02% | 694 |
|
|
2021
Q2 | $13.6M | Sell |
162,594
-198
| -0.1% | -$16.5K | 0.02% | 602 |
|
|
2021
Q1 | $12.3M | Sell |
162,792
-14,313
| -8% | -$1.08M | 0.02% | 594 |
|
|
2020
Q4 | $15.5M | Buy |
177,105
+7,645
| +5% | +$670K | 0.03% | 469 |
|
|
2020
Q3 | $12.9M | Buy |
169,460
+18,870
| +13% | +$1.44M | 0.03% | 466 |
|
|
2020
Q2 | $18.6M | Sell |
150,590
-7,183
| -5% | -$886K | 0.04% | 341 |
|
|
2020
Q1 | $13.6M | Buy |
157,773
+32,824
| +26% | +$2.82M | 0.04% | 365 |
|
|
2019
Q4 | $10.8M | Buy |
124,949
+3,490
| +3% | +$300K | 0.02% | 578 |
|
|
2019
Q3 | $8.25M | Buy |
121,459
+20,352
| +20% | +$1.38M | 0.02% | 634 |
|
|
2019
Q2 | $8.82M | Buy |
101,107
+30,735
| +44% | +$2.68M | 0.02% | 624 |
|
|
2019
Q1 | $6.36M | Buy |
70,372
+25,012
| +55% | +$2.26M | 0.02% | 702 |
|
|
2018
Q4 | $3.95M | Buy |
45,360
+5,076
| +13% | +$442K | 0.01% | 872 |
|
|
2018
Q3 | $3.89M | Buy |
40,284
+4,666
| +13% | +$450K | 0.01% | 940 |
|
|
2018
Q2 | $3.35M | Buy |
35,618
+26,197
| +278% | +$2.46M | 0.01% | 973 |
|
|
2018
Q1 | $755K | Buy |
9,421
+5,103
| +118% | +$409K | ﹤0.01% | 1739 |
|
|
2017
Q4 | $382K | Sell |
4,318
-730
| -14% | -$64.6K | ﹤0.01% | 2068 |
|
|
2017
Q3 | $470K | Sell |
5,048
-876
| -15% | -$81.6K | ﹤0.01% | 1916 |
|
|
2017
Q2 | $539K | Buy |
5,924
+732
| +14% | +$66.6K | ﹤0.01% | 1822 |
|
|
2017
Q1 | $452K | Sell |
5,192
-2,291
| -31% | -$199K | ﹤0.01% | 1873 |
|
|
2016
Q4 | $617K | Buy |
7,483
+1,315
| +21% | +$108K | ﹤0.01% | 1665 |
|
|
2016
Q3 | $568K | Buy |
6,168
+2,424
| +65% | +$223K | ﹤0.01% | 1653 |
|
|
2016
Q2 | $292K | Sell |
3,744
-1,349
| -26% | -$105K | ﹤0.01% | 2055 |
|
|
2016
Q1 | $420K | Buy |
5,093
+1,600
| +46% | +$132K | ﹤0.01% | 1675 |
|
|
2015
Q4 | $366K | Buy |
+3,493
| New | +$366K | ﹤0.01% | 1816 |
|